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ABSTRACT 
Aprocess for propagating a pathogen in a three-dimensional 
tissue mass cultured at microgravity conditions in a culture 
vessel containing culture media and a culture matrix is 
provided. The three-dimensional tissue mass is inoculated 
with a pathogen and pathogen replication in the cells of the 
tissue mass achieved. 
20 Claims, 3 Drawing Sheets 
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PATHOGEN PROPAGATION IN CULTURED 
THREE-DIMENSIONAL TISSUE MASS 
This application is a continuation-in-part of U.S. Ser. No. 
081066,292, filed May 25, 1993, now U.S. Pat. No. 5,496, 
722, which is a continuation-in-part of U.S. Ser. No. 071939, 
791, filed Sep. 3, 1992, now U.S. Pat. No. 5,308,764 which 
is a continuation of U.S. Ser. No. 071317,921, filed Mar. 2, 
1989, now U.S. Pat. No. 5,007,497 which is a continuation- 
in-part of U.S. Ser. No. 071317,776, filed Mar. 2, 1989, now 
U.S. Pat. No. 5,155,034 and is a continuation of U.S. Ser. 
No. 071213,558, filed Jun. 30, 1988, now U.S. Pat. No. 
5,026,650 and a continuation-in-part of U.S. Ser. No. 
071625,345, filed Dec. 11, 1990, now U.S. Pat. No. 5,153, 
131. 
ORIGIN OF THE INVENTION 
The invention described herein was made in the perfor- 
mance of work under a NASA contract and is subject to the 
provisions of Section 305 of the National Aeronautics and 
Space Act of 1958, Public Law 85-568 (72 Stat. 435; 42 
U.S.C. 2457). 
FIELD OF THE INVENTION 
The invention relates to propagating a pathogen selected 
from the group consisting essentially of viruses, bacteria, 
protozoans, parasites, and fungi, by inoculating a three- 
dimensional tissue mass cultured at microgravity conditions 
in fluid culture media in a microgravity vessel with the 
pathogen. The three-dimensional tissue mass may be cul- 
tured from normal or abnormal mammalian cells. 
BACKGROUND OF THE INVENTION 
Cell culture processes have been developed for the growth 
of single cell bacteria, yeast and molds, which are resistant 
to environmental stresses or are encased within a tough cell 
wall. Mammalian cell culture, however, is much more 
complex because the cells are delicate and cannot withstand 
excessive turbulent action without sustaining damage. 
Moreover, mammalian cell cultures require complex nutri- 
ent media and environment to support cell proliferation and 
growth; and it is frequently required that the cells attach 
themselves to some substrate surface to remain viable and to 
duplicate. The particular culture requirements of mamma- 
lian cells make successful in vitro culturing of both normal 
and abnormal (for example, carcinomas) mammalian cells 
difficult to achieve. 
There is a lack of adequate in vitro culture systems which 
produce mammalian tissue of sufficient size and function- 
ality to allow subsequent study of the tissue or study of the 
effects of specific compounds or organisms on the tissue. 
Elaborate culture systems for normal and abnormal mam- 
malian cells have been developed in an attempt to grow 
tissues, however, most do not mimic in vitro conditions and 
have many limiting aspects. 
Normal mammalian tissue has been grown for limited 
periods of time as two-dimensional monolayers on gelled 
substrate or other surface for anchoring the cells. Buset et al. 
“Defining Conditions to Promote the Attachment of Adult 
Human Colonic Epithelial Cells”, In Vltro Cell. & Dev. Biol., 
Vol. 23. No. 6 pp. 403-412 (June 1987). Colonic cell 
cultures surviving longer than 7 weeks have been difficult to 
achieve since crypt cells are unable to survive standard 
culture regimens, and two-dimensional organ cultures do not 
support the de novo assembly of stroma and its contribution 
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to epithelial cell growth. Shamsuddin, “Colon Organ Culture 
as a Model for Carcinogenesis”, Colon Cancer Cells, Moyer 
and Poste, Eds. Academic Press, Inc. 1990. 
To mimic the in situ environment using monolayer 
culture, cocultures were prepared using two cell types. A 
“feeder layer” of fibroblasts or other cells supplied the 
primary cells with nutrients and other factors difficult to 
incorporate into a substrate and provided the cellular inter- 
action believed to be necessary for the production of differ- 
entiated tissue. Reid et al., “Culturing Hepatocytes and 
Other Differentiated Cells”, Hepatology, Vol. 4, No. 3, pp. 
548-559 (1984); Haake et al. “Retention of Differentiated 
Characteristics in Human Fetal Keratinocytes In Vitro”, In 
Vltro Cell. & Dev Biol., Vol. 25 No. 25 pp. 592-600 (July 
1989). 
Monolayers “conditioned” with fibroblast cells have been 
used to impart into the substrate the soluble growth factors 
for epithelial cells. Kabalin et al. “Clonal Growth of Human 
Prostatic Epithelial Cells Is Stimulated by Fibroblasts”, The 
Prostate, Vol. 14, pp. 251-263 (1989). Monolayers do not 
produce a three-dimensional tissue, but rather a two- 
dimensional spread of cells. Often the cells developed by 
monolayer culture and coculture become undifferentiated 
and lack normal function. 
Three-dimensional in vitro models of differentiated tissue 
have been produced, however, the cells often do not dem- 
onstrate normal cellular activity. Embryonic avian skeletal 
muscle cells have been grown in vitro on expandable 
membranes which are gradually and substantially, continu- 
ously stretched to simulate the mechanical stimulation of 
cells experienced in vivo. U.S. Patent No. 4,940,853, 
Method for Growing Tissue Specimens in Vitro, 
Vadenburgh, Jul. 10, 1990. The expandable support mem- 
brane supports development of three-dimensional structures 
more closely resemble tissue grown in vivo, however, nor- 
mal independent cellular activity has not been identified. 
Additionally, three-dimensional human mammary epithelial 
cells have been grown in collagen. U.S. Pat. No. 5,026,637, 
Soule, et al., Jun. 25, 1991. The cells under the disclosed 
culture conditions did not undergo terminal differentiation 
and cell senescence, but rather were “immortal” in that they 
retained the capacity to divide. Thus, normal cellular activity 
and naturalization was not observed. 
A variety of different cells and tissues, such as bone 
marrow, skin, liver, pancreas, mucosal epithelium, adeno- 
carcinoma and melanoma, have been grown in culture 
systems to provide three-dimensional growth in the presence 
of a pre-established stromal support matrix. U.S. Pat. No. 
4,963,489, Three-Dimensional Cell and Tissue Culture 
System, Naughton, et al., Oct. 16, 1990; U.S. Pat. No. 
5,032,508, Three-Dimensional Cell and Tissue Culture 
System, Naughton, et al., Jul. 16, 1991. A biocompatible, 
non-living material formed into a three-dimensional struc- 
ture is inoculated with stromal cells. In some cases, the 
three-dimensional structure is a mesh pre-coated with col- 
lagen. Stromal cells and the associated connective tissue 
proteins naturally secreted by the stromal cells attach to and 
envelop the three-dimensional structure. The interstitial 
spaces of the structure become bridged by the stromal cells, 
which are grown to at least subconfluence prior to inocu- 
lating the three-dimensional stromal matrix with tissue- 
specific cells. 
Similar difficulties experienced with normal cell and 
tissue cultures have been observed with culture systems for 
propagating abnormal cells and tissues. Although several 
human carcinoma cell lines have been propagated in vitro, 
6,117,674 
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present in vitro culture systems do not permit reproducible 
cultures of neoplastic cells in large-scale, three-dimensional 
configuration. The culture of most neoplastic cells has a low 
Vol. 96 (Part l) ,  pp. 756-761 (1982). Nonvalk infection 
produces a brief illness characterized primarily by nausea, 
vomiting, diarrhea, and abdominal cramps. The acute gas- 
SUCCeSS rate, with low percentages of neoplastic cells being troenteritis produced by Nonvalk virus is an extraordinarily 
established in vitro. Success in cancer therapy can be greatly s common, worldwide disease with a significant Public health 
enhanced using therapeutic testing in models that closely impact. In the United States, it is second in frequency only 
resemble tumorous tissue in vivo and/or in situ. to acute viral respiratory disease as a disease occurrence in 
American families. D o h ,  et al., “Novel Agents of Viral 
Enteritis in Humans”, The Journal of Infectious Diseases, High-density, three-dimensional in vitro growth of mam- 
malian tumor cells is problematic due to the effects of shear, vel, 155, No, 3, pp, 365-376 (March 1987), Worldwide, it 
turbulence, and inadequate oxygenation in conventional cell 10 is estimated that greater than 700 million of acute 
diarrheal disease occur annually in children less than 5 years 
have been grown in containers with small microwells to of age, and such disease may be associated with as many as 
provide surface anchors for the cells. However, cell culture a 5 million deaths, primarily in developing countries, 
processes for mammalian cells in such microwell containers Norwalk is a part of the group known as small round 
generally do not Provide sufficient surface area to grow structured gastroenteritis viruses (20-30 nm in diameter). 
mammalian cells on a sufficiently large scale basis for many ~ ~ ~ ~ l k  has a diameter of approximate~y 27 nm, and has 
commercial or research applications. been difficult to successfully propagate in the laboratory. 
Coculture of tumor and normal cells in solid-state culture Immunological measurements of susceptibility to Norwalk 
has been reported as shown in U.S. Pat. No. 4,352,887, infection remain unknown because neither humoral nor 
Method and Article for Culturing Differentiated Cells, Reid 2o secretory antibody appears to correlate immunity to infec- 
et al., Oct. 5, 1982. However, the three-dimensional envi- tion. 
ronment and culture did not achieve standard clinical testing The supply of infectious ~ ~ ~ ~ l k  virus material is pro- 
protocol, such that the three-dimensional environment is duced primarily through the production of the disease in 
nurtured by a mixed-bed of tumor and normal cells. volunteers. The infectious material produced provides mate- 
It is important that tumor models utilized in vitro mimic 2s rial for laboratory study of etiologic agents and an experi- 
in vivo properties of tumor cell lines in order that tumor mental host in which important biophysical and immuno- 
genesis and tumor cell invasiveness can be observed. logical properties of etiologic agents can be defined. 
Although animal models are useful for studying carcinomas, Blacklow et al., “Acute Infectious Nonbacterial Gastroen- 
many biochemical and molecular studies require that cells teritis: Etiology and Pathogenesis”, Annals of Internal 
be grown in vitro. Studies on carcinoma cell lines have Medicine, 76:993-1008 (1972). Such studies also provide 
centered around the expression of oncogenic and protoon- the opportunity to study the clinical course and pathogenesis 
cogenic markers and nucleotide sequences in order to elu- of the disease. These methods of studying a virus, however, 
cidate the etiology of malignant transformation. Studies pose some risk to the infected volunteers. 
have led to insight and speculation as to the origin of 3s Various tissue culture procedures for propagating viruses 
transformation, the genetics of transformation, and the treat- have been proposed, however, most are tedious and time 
ment or inhibition of the transformation process. However, consuming acute infection procedures, Such procedures 
the models studied have lacked sufficient fidelity for require multiple passages of cell free virus in tissue culture 
adequate comparison of in vitro culture systems to obser- before an acceptable virus titer is obtained. The infected cell 
vations in situ. 4o culture is grown to confluency and the grown cells allowed 
Traditional in vitro tumor models have failed to provide to age. The aged cells are lysed and the virus extracted. The 
intact cell subpopulations, stable isoenzyme patterns, stable extracted virus can be used to infect a new cell culture. 
ploidy, stable and broad-based growth patterns, and high- Avariety of cell cultures can be maintained in monolayers 
fidelity expression of specific cellular proteins. Large scale, on the smooth surface of a solid support, e.g., Petri dishes, 
high-fidelity three-dimensional in vitro culture carcinoma 4s glass bottles, or tubes. Soon as such cultures become 
models are necessary to studying developmental, mutagenic, confluent, forming a united layer of uniform thickness, a 
metastagenic and transformation properties of carcinomas. virus may be introduced into the liquid medium covering the 
The ability to prepare adequate tissue models will provide cells. 
an in vivo-like environment for propagating pathogens, Many types of cells can also be grown in suspension, 
which frequently cannot be propagated otherwise without so being dispersed within nutrient medium. Avirus may then be 
great difficulty. For example, viruses are typically intracel- propagated in the suspended cells. In the conventional 
lular parasites, and cannot be grown in the laboratory unless system, the fluid medium is decanted off the suspended cells 
the growing medium contains living cells. when peak cell concentration is reached. The cells are 
Generally, little is known about the mechanism by which resuspended in fresh medium which also carries a virus seed. 
a viral infection induces certain changes in the activity of the 5s After the period of virus growth, determined by observations 
normal functions of the host organism. For example, much of the cytopathic effect of the cells, the harvest is usually 
of the material collected and known about Norwalkvirus has passed through a filter and then through a bacterial steriliz- 
been obtained from studies of infected volunteers because in ing membrane to obtain a solution which contains free 
vitro systems for cultivation of the virus, as with many other viruses released by the disrupted cells. 
viruses, have not yet been devised. Studies with cultured cell 60 A disadvantage of large scale suspended cultures of 
explants often result in the Nonvalk virus not producing mammalian cells is that air must be sparged through the 
cytopathic changes in the cells. medium at a high rate and may damage the cells. Further, the 
Norwalk virus plays a significant role in sporadic illness sedimentation of the cells is a time-consuming process, and 
and in outbreaks of acute nonbacterial gastroenteritis. the sedimented cells may be subjected to a medium envi- 
&plan, et al., ‘‘Epidemiology of Norwalk Gastroenteritis 65 ronment unfavorable in terms of pH and nutritional factors. 
and the Role of Norwalk Virus in Outbreaks of Acute The inability to propagate viruses in cell culture fre- 
Nonbacterial Gastroenteritis”, Annals of Internal Medicine, quently necessitates the use of susceptible sub-human pri- 
systems. On a tumor 
30 
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mates to grow a particular virus so as to obtain antigen for 
diagnostic and therapeutic purposes. For example, sub- 
human primates may be infected with the hepatitis A virus, 
the infected liver removed, and used to inoculate an in vitro 
cell culture. U.S. Pat. No. 4,164,566, Hepatitis A Virus Cell 
Culture in Vitro, Provost et al., Aug. 14, 1979. The cell 
culture is incubated until hepatitis A antigen is detectable in 
the culture cells or fluid. Two serial in vitro passages in cell 
culture are carried out. The hepatitis Avirus so modified can 
be used to prepare live, attenuated hepatitis Avaccine or an 
inactivated hepatitis Avaccine. Such practices, however, are 
impractical for commercial use. 
Eucaryotic cells have been cultured within a solid carrier 
body or bed, which is either porous or in a particulate state 
to provide sufficient internal cavities or space for immobi- 
lizing and growing cells and to allow liquid media to pass 
through the solid carrier and interact with the cells. U.S. Pat. 
No. 4,203,801, Cell and Virus Culture Systems, Telling, et 
al., May 20, 1980. The carrier may consist of natural or 
synthetic materials, such as silicates of diatomaceous earth 
or polymer particles. A selected cell line is initiated in a 
monolayer or suspension culture and propagated until the 
maximum concentration in the cell culture is achieved. The 
cells are then passed through the bed, whereby the cells are 
immobilized in the bed. Medium is added to the system and 
a seed virus introduced. After the cells are disrupted by the 
virus infection, virus is released and carried away by the 
medium. Viral material can then be separated from the 
medium and is available for vaccine formulation or other 
uses. 
Hepatitis A virus has been propagated in human liver 
tumor cells grown in petri dishes containing nutrient media 
until the cells reached confluency. U.S. Pat. No. 4,721,675, 
Production of Hepatitis A Virus in vitro Utilizing a Persis- 
tently Virus Infected Cell Culture System, Chan et al., Jan. 
26, 1988. The cells were then infected with a single treat- 
ment of an inoculum obtained from a human clinical speci- 
men containing the hepatitis Avirus. The cell culture system 
enabled propagating a persistently infected virus producing 
cell line for passage to other cultures. The system, however, 
did not mimic in vivo conditions. 
U.S. Pat. No. 5,032,508, Three-Dimensional Cell and 
Tissue Culture System, Naughton, et al., Jul. 16, 1991, 
discloses a three-dimensional culture system which can be 
used to culture a variety of different cells and tissues. The 
tissue cultures grown were proposed for use as a model 
system for the study of physiologic or pathologic conditions, 
such as using mucosal epithelium as a model system to study 
herpes virus or papillomavirus infection. The tissue cultures 
disclosed by Naughton are initiated using a composite layer 
taken from a mesenchymal component. Since single cells 
are not used, it is difficult to define cellular interstitial 
matrices. The culture system resembles a two-dimensional 
culture system and it will be difficult to produce the extra- 
cellular matrix and interstitial components to allow virus 
cells to translocate from cell to cell. 
Difficulties in propagating the Nonvalk virus in vitro has 
precluded the development of commercially available diag- 
nostic assays. A major obstacle to successfully propagating 
Nonvalk virus in vitro is due to the small amount of virus in 
the stool available for inoculation. Moreover, suitable ani- 
mal models for the study of these viruses are not available. 
Relatively little information is available regarding the bio- 
physical and biochemical characteristics of these agents, and 
for the most part, their significance as etiologic agents of 
gastroenteritis remains to be established. Understanding of 
the pathogenesis and immune responses to these agents is at 
6 
the early stages, and factors responsible for susceptibility of 
a viral infection remain poorly understood. Since it is 
difficult to concentrate the virus inoculum, improved cell 
lines that mimic normal human small intestine tissue would 
5 be invaluable for producing larger quantities of virus. 
Three-dimensional normal and abnormal cell aggregates 
and growth achieved in a microgravity vessel provide a 
unique system in which to simulate the conditions of clinical 
therapy in vitro. Normal and abnormal mammalian cells 
cultured in bioreactors, or microgravity vessels, providing 
low shear and essentially no relative motion of the culture 
environment with respect to the walls of the culture vessel 
grow and proliferate to form three-dimensional tissue 
masses similar to tissues in vitro. Designs for bioreactors 
which enable such cell and tissue growth are disclosed in 
U.S. Pat. Nos. 4,988,623, 5,026,650 and 5,153,131. 
The three-dimensional tissue masses produced in the 
bioreactors in vitro permit inoculating the tissue mass with 
a pathogen to observe the infection produced by the patho- 
gen under conditions closely resembling those in vivo. The 
20 culture system provides for proliferation and appropriate cell 
maturation to form structures analogous to tissue counter- 
parts in vivo. The system enables replicating a pathogen, 
such as a virus, having biophysical, morphological, 
immunological, and biological properties characteristic of 
25 the pathogen isolated from human sources. The resulting 
culture may be used to screen cytotoxin compounds and 
pharmaceutical compounds in vitro, and to produce biologi- 
cally active molecules in bioreactors. The use of mircro- 
gravity vessels in studying pathogens such as viruses will 
30 aid in understanding the pathogenesis by which viral agents 
cause illness. 
The three-dimensional tissues produced from cells taken 
from different mammalian systems can serve as a model for 
therapeutic trials directed toward particular pathogens prior 
35 to in vivo experimentation. Pathogen therapies, such as 
radiation, chemotherapy and drugs, can be tested using 
pathogen infected three-dimensional tissue masses grown 
under microgravity conditions. For example, the efficacy of 
anti-viral medications can be tested using virus infected 
40 tissue masses grown in microgravity vessels. The develop- 
ment of a means for culturing viruses will enable performing 
neutralizing antibody studies. Such studies are critical 
toward the analysis of host short term and long term immune 
responses to viruses, such as Norwalk. Viral propagation in 
45 a three-dimensional tissue mass grown in a microgravity 
vessel will provide a means by which host immune response 
to viral infection can be evaluated. Vaccines could then be 
evaluated for their ability to induce neutralizing responses. 
so SUMMARY OF THE INVENTION 
Pathogens have been propagated in vitro in three- 
dimensional tissue masses. Mammalian cells were cultured 
at microgravity conditions in a culture vessel containing 
culture media and a culture matrix to form a three- 
ss dimensional tissue mass. The culture vessel was inoculated 
with a pathogen and microgravity culture conditions 
maintained, whereby pathogen replication is achieved in the 
cells forming the three-dimensional tissue mass. Normal 
mammalian cells cam be cultured to form a three- 
60 dimensional tissue mass. The normal mammalian cells may 
be selected from the group consisting essentially of epithe- 
lial cells, mesenchyme cells, fibroblasts, and mixtures 
thereof. Abnormal mammalian cells, such as carcinoma cells 
may also be cultured to form a three-dimensional carcinoma. 
65 In the preferred embodiment, the normal mammalian cells 
are a mixture of small intestine epithelial cells and mesen- 
chyme cells. 
6,117,674 
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The normal mesenchyme cells may be cultured at micro- 
gravity conditions for a preselected time prior to adding 
normal epithelial cells to the culture vessel. Normal mam- 
malian cells may also be cultured at microgravity conditions 
for a preselected time prior to adding carcinoma cells to the 
culture vessel. The microgravity culture conditions are cre- 
ated by having a culture vessel in microgravity or by 
simulating microgravity. Microgravity culture conditions 
are created by having a horizontally rotating culture vessel 
in unit gravity producing the simultaneous conditions of (1) 
collocation of cells and culture matrix with similar or 
differing sedimentation properties in a similar spatial region, 
(2) freedom for three dimensional spatial orientation of 
tissues formed by the culturing of the cells and (3) low shear 
and essentially no relative motion of the culture environment 
with respect to the walls of the culture vessel. The culture 
media volume may be reduced prior to introducing the 
pathogen. 
The preferred culture media comprises fetal bovine serum 
and a tri-sugar based medium selected from mixtures of the 
group consisting of fructose, galactose, and glucose. The 
preferred culture matrix comprises generally spherical 
microcarriers. 
The pathogen may be selected from the group consisting 
essentially of viruses, bacteria, protozoans, parasites, and 
fungi. In the preferred process and embodiment of the 
invention, the pathogen is Norwalk virus. The three- 
dimensional tissue mass culture is maintained until tissue 
cell shedding occurs. The pathogen can be passaged to 
another cell line under culture conditions. The pathogen 
products, particularly viral proteins, produced by the process 
may be used in the development of vaccines or for other 
purposes. A pathogen inoculum produced from the process 
may be used for subsequent culture inoculations or for other 
purposes. 
Aprocess for testing the efficacy of a therapeutic agent is 
also provided. Mammalian cells are cultured at microgravity 
conditions in a culture vessel containing culture media and 
a culture matrix until the cells form a three-dimensional 
tissue mass. The three-dimensional tissue mass is inoculated 
with a pathogen. The microgravity culture conditions are 
maintained whereby pathogen replication in the cells form- 
ing the three-dimensional tissue mass is achieved. A thera- 
peutic agent is introduced to the culture vessel, and the effect 
of the therapeutic agent on the pathogen is determined. The 
therapeutic agent is selected from the group consisting 
essentially of vaccines, drugs, radiation, and immunothera- 
peutic agents. 
Normal mammalian cells may be selected from the group 
consisting essentially of epithelial cells, mesenchyme cells, 
fibroblasts, and mixtures thereof and cultured to form a 
three-dimensional tissue mass. Abnormal mammalian cells, 
such as carcinoma cells may also be cultured. The normal 
mammalian cells may be a mixture of small intestine epi- 
thelial cells and mesenchyme cells. 
The normal mesenchyme cells may be cultured at micro- 
gravity conditions for a preselected time prior to adding 
normal epithelial cells to the culture vessel. Normal mam- 
malian cells may also be cultured at microgravity conditions 
for a preselected time prior to adding carcinoma cells to the 
culture vessel. The microgravity culture conditions are cre- 
ated by having a culture vessel in microgravity or by 
simulating microgravity. Microgravity culture conditions 
are created by having a horizontally rotating culture vessel 
in unit gravity producing the simultaneous conditions of (1) 
collocation of cells and culture matrix with similar or 
8 
differing sedimentation properties in a similar spatial region, 
(2) freedom for three dimensional spatial orientation of 
tissues formed by the culturing of the cells and (3) low shear 
and essentially no relative motion of the culture environment 
5 with respect to the walls of the culture vessel. The culture 
media volume may be reduced prior to introducing the 
pathogen. 
The preferred culture media comprises fetal bovine serum 
and a tri-sugar based medium selected from mixtures of the 
group consisting of fructose, galactose, and glucose. The 
preferred culture matrix comprises generally spherical 
microcarriers. 
The pathogen may be selected from the group consisting 
essentially of viruses, bacteria, protozoans, parasites, and 
15 fungi. The pathogen selected may be Norwalk virus. The 
three-dimensional tissue mass culture is maintained until 
tissue cell shedding occurs. The pathogen can be passaged to 
another cell line under culture conditions. 
Aprocess for testing a gene therapy regimen is provided. 
20 Mammalian cells are cultured at microgravity conditions in 
a culture vessel containing culture media and a culture 
matrix until the cells form a three-dimensional tissue mass. 
A virus having a desired genome is introduced into the 
vessel. The microgravity culture conditions are maintained 
25 to allow genetic material from the genome of the virus to 
incorporate into the cells forming the three-dimensional 
tissue mass. Whether the cells forming the three- 
dimensional tissue mass contain altered genetic material is 
determined. The virus may be manipulated to include 
Normal mammalian cells may be selected from the group 
consisting essentially of epithelial cells, mesenchyme cells, 
fibroblasts, and mixtures thereof and cultured to form a 
three-dimensional tissue mass. Abnormal mammalian cells, 
3s such as carcinoma cells may also be cultured. The normal 
mammalian cells may be a mixture of small intestine epi- 
thelial cells and mesenchyme cells. DNA fragments of 
genetic material may be harvested from the cells of the 
three-dimensional tissue mass. 
The normal mesenchyme cells may be cultured at micro- 
gravity conditions for a preselected time prior to adding 
normal epithelial cells to the culture vessel. Normal mam- 
malian cells may also be cultured at microgravity conditions 
for a preselected time prior to adding carcinoma cells to the 
45 culture vessel. The microgravity culture conditions are cre- 
ated by having a culture vessel in microgravity or by 
simulating microgravity. Microgravity culture conditions 
are created by having a horizontally rotating culture vessel 
in unit gravity producing the simultaneous conditions of (1) 
SO collocation of cells and culture matrix with similar or 
differing sedimentation properties in a similar spatial region, 
(2) freedom for three dimensional spatial orientation of 
tissues formed by the culturing of the cells and (3) low shear 
and essentially no relative motion of the culture environment 
55 with respect to the walls of the culture vessel. The culture 
media volume may be reduced prior to introducing the virus. 
The preferred culture media comprises fetal bovine serum 
and a tri-sugar based medium selected from mixtures of the 
group consisting of fructose, galactose, and glucose. The 
60 preferred culture matrix comprises generally spherical 
microcarriers. 
30 desired genetic material in its genome. 
40 
BRIEF DESCRIPTION OF THE DRAWINGS 
FIG. 1 is a view at 200x magnification of a three dimen- 
FIG. 2 is a photograph of artificial normal organ tissue at 
65 sional artificial normal organ tissue mass. 
200x magnification. 
6,117,674 
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FIG. 3 is a photograph of artificial normal organ tissue at 
FIG. 4 is a photograph of artificial normal organ tissue at 
FIG. 5 is a photograph of artificial normal organ tissue at 
lial cells were passaged by dilution at a 1:2 ratio into fresh 
M3:2 medium in T-flasks. Cultures of epithelial cells were 
derived from the ileum and jejunum of three male donors 
(22-35 years of age). Mesenchymal cells were obtained 
from the submucosa Of five donors (4 17-27 years Old 
and a 2-month-old female). 
Normal mesenchymal cells were removed from T-75 
flasks by enzymatic digestion, washed once with calcium- 
and magnesium-free phosphate buffer solution (CMF-PBS), 
The processes and products of the invention are described lo and assayed for viability by Trypan Blue dye exclusion 
(GIBCO). Cells were held on ice in fresh growth medium 
until inoculation. In the preferred process the primary inocu- 
lum introduced into the culture vessel was 2x10’ mesen- 
ChYmal cellS/ml in a 125-ml volume with 5 m d m l  
Cytodex-3 micro-carrier beads (Pharmacia, Piscataway, 
N.J.1. CYtodex-3 miaocarriers were TYPe 1, collage-coated 
dextran beads, 175 microns in diameter. After the primary 
i m ~ u l u m  was Prepared for seeding, it was transferred to a 
culture vessel filled with culture media and cultured at 
500x magnification. 
1500x magnification. 
50x magnification. 
DETAILED DESCRIPTION OF THE 
INVENTION 
for both normal and abnormal mammalian tissue used to 
produce the pathogen and pathogenic products. The follow- 
ing examples are illustrative of the present invention. 
In one example, small intestine epithelial and mesen- 
chyme cells were cultured at microgravity conditions to 
form three-dimensional tissue masses. The microgravity 
conditions were maintained in a culture vessel containing 
culture media and a culture matrix. The artificially produced 
three-dimensional small intestine tissue exhibited nor- 
mal morphology and cell function. After 45-50 days, the 2o microgravity conditions. 
three-dimensional small intestine tissue mass was inoculated 
with Norwalk virus 8FIIa and viral replication achieved. The 
Nonvalk virus was selected for inoculation because it has 
In the preferred process the microgravity conditions were 
simulated in unit gravity by a horizontal rotating wall vessel 
(RWV). A preferred RWV bioreactor is described in U.S. 
is incorporated by reference herein, The rotation of the 
been traditionally difficult to Propagate in in vitro culture. 2s Pat. No. 5,026,650 to Schwarz et al. issued Jun. 25,1991 and 
systems, such as HePatitis c and HIV and related viruses culture vessel (bioreactor) was controlled to produce the 
associated with acquired immune deficiency syndrome may simultaneous conditions of (1) collocation of cells and 
be Propagated using the Process described herein. Three- culture matrix with similar or differing sedimentation prop- 
h y  virus difficult to culture in vitro using known culturing 
dimensional small intestine tissue masses were selected for 3o erties in a similar spatial region, (2) freedom for three 
Nonvalk virus infection because the small intestine is the dimensional spatial orientation of tissues formed by the 
organ in which the virus propagates in situ. culturing of the cells and (3) low shear and essentially no 
The processes described herein for culturing a three- relative motion of the culture environment with respect to 
dimensional small intestine tissue mass may be used to the walls of the culture vessel. The trajectory of the cell 
culture tissue masses from cells of other origins, such as 3s aggregates was determined. The speed of the rotation of the 
blood tissue or structural tissue. The selection of the tissue culture vessel was increased if the cell aggregates fell 
of cell origin will be dependant upon the pathogen sought to excessively inward and downward on the downward side of 
be propagated. the rotational cycle and excessively outward and insuffi- 
tine tissue mass was generated from normal small intestine 40 Prevent wall impact. The rotation of the culture vessel was 
The artificially produced three-dimensional small intes- ciently upward on the upgoing side of the rotational cycle to 
epithelial and mesenchymal cells, Human small intestine decreased in response to excessive accumulation of tissue 
epithelial and mesenchymal cells were obtained from nor- aggregation near the outer wall of the culture vessel SO as not 
mal organs of patients, predominantly organ transplant to restrict three dimensional growth. AS the tissue aggregates 
donors, showing no evidence of disease, The cells were then grow the rotation was adjusted to obtain minimal collision 
propagated in culture. 
The cells were initiated and propagated in M3 media The culture media used in the RWV can be varied. A 1 : l  
supplemented with 2% fetal bovine serum (FBS), designated mixture of M3:2 medium and standard minimal essential 
M3:2, for epithelial cells or with 10% FBS, designated medium-alpha (MEM-alpha) (GIBCO) supplemented with 
M3:10, for mesenchymal cells. M3 medium is a complex 10% FBS was used. A preferred media designated GTSF-2 
base medium supplemented with many growth factors and so was found to meet the growth requirements of the system 
nutrients including L-Broth (tryptone broth), bovine pitu- without the need for unique growth factors and other com- 
amino acids, pentagastrin, epidermal growth factor, GTSF-2 media is a trisugar-based medium with glucose, 
4s frequency and intensity. 
itary extract, hydrocortisone, essential and non-essential plex components found in other media including M3:2. The 
transferrin, selenium, and insulin. Moyer, “Methods for galactose and fructose supplemented with 6% FBS. A pre- 
Propagation and Characterization of Human GI and Other ss ferred formulation for GTSF-2 media is listed in Table 1 
Cells for Study of HIV,” J .  T ~ s .  Cult. Meth., VO~. 13, PP. below. The pH was adjusted to 7.4 with 1N NaOH. 
107-116 (1991). 
All cell cultures were grown in a Forma humidified CO, 
incubator with 95% air, 5% CO,, and constant atmosphere 
at a temperature of 37” C. Normal mesenchymal cells were 60 
passaged as required by enzymatic dissociation with a 
TABLE 1 
Tri-Sugar Based Medium 
GTSF-2 
solution of 0.1% Trypsin, 0.1% EDTA, for 15 minutes at 37” 
C. After incubation with the appropriate enzymes, the cells Component Concentration Designation 
SourceIOrder or 
400 ml (40%) GIBC0/430-1900EB were centrifuged at 800xG f i r  i 0  minutks in Corning 
conical 15-ml centrifuge tubes. The cells were then resus- 65 ted with 2.25  em/^ 
MEM-alpha supplemen- 
pended in fresh medium and diluted into Corning T-flasks 
with 25 ml of fresh growth medium. Small intestine epithe- 
NaHCO, 
6,117,674 
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TABLE 1-continued 
Tri-Sugar Based Medium 
GTSF-2 
SourceiOrder or 
Component Concentration Designation 
L-15 
NaHCO, 
HEPES 
Folic acid 
0.5% Nicotinic acid 
Bactopeptone 
I-inositol 
Fructose 
Galactose 
D-Glucose 
300 mM L-Glutamine 
Gentamycin 
Fungizone 
Insulin-transferrin- 
sodium-solenite 
Fetal bovine serum 
600 ml (60%) 
1.35 gmiliter 
3.0 gmiliter 
6.667 ,@liter 
0.667 mliliter 
0.6 gmiliter 
0.024 gmiliter 
0.13 gmiliter 
0.25 gmiliter 
1.0 gmiliter 
10 mliliter 
1 mliliter 
2 mliliter 
5 mliliter 
GIBC0/430-1300EB 
Sigmais-5761 
Research Or- 
ganicsi6003H-2 
SigmaiF-8758 
SigmaiN-4126 
Difcoi0118-01 
SigmaiI-5125 
SigmaiF-3510 
SigmaiG-5388 
SiginaiG-5250 
SigmaiG-5763 
GIBC0/600-5750AD 
GIBC0/600-5295AE 
SigmaiI- 1884 
60 ml (6%) HycloneiA-1111-L 
The primary inoculum of mesenchymal cells was allowed 
to grow for a minimum of 2-3 days before the medium was 
changed. Then 2x10’ epithelial cellsiml were added pre- 
pared as described above for the mesenchymal cells. The 
organ tissue can be bioengineered to develop desired pat- 
terns of cell layering by preselecting the introduction of the 
epithelial cells into the culture vessel. Also, the cells can be 
introduced essentially simultaneously into the vessel to 
produce normal organ tissue. 
Culture conditions included mass transfer with exchange 
of nutrients for metabolic waste and appropriate gas 
exchange in the culture system. Fresh medium was replen- 
ished by 65% of the total vessel volume each 20 to 24 hours. 
As metabolic requirements increased, fresh medium was 
supplemented with an additional 100 mgidl of glucose. 
The three-dimensional small intestine tissue mass may be 
produced in the RWV in both a 1 : l  mixture of M3:2 and 
MEM alpha supplemented with 10% fetal bovine serum 
(Hyclone Laboratories, Logan, Utah) and tri-sugar based 
media shown in Table 1 on a preferred culture matrix of 5 
mgiml Cytodex-3 generally spherical microcarriers 
(Pharmacia, LKB). In alternate embodiments, the tissue 
mass can be grown in a 1: 1 mixture of M3:2 and MEM alpha 
supplemented with 10% fetal bovine serum (Hyclone 
Laboratories, Logan, Utah). 
The preferred tri-sugar based media was found to meet the 
growth requirements without the need for multiple growth 
factors and supplements. The three-dimensional small intes- 
tine tissue mass grown in the tri-sugar based media exhibited 
an epithelial cell component which appeared to proliferate in 
a more normal fashion. The cultures were not grown to the 
plateau phase, indicating further capability for continued 
growth. The artificial tissue did not reach maximum cell 
densities after 38-45 days of culture. 
The tissue masses grew to relatively large sizes as com- 
pared to other in vitro methods. After 300 hours of culture, 
the tissueimicrocarrier mass was about 0.2-0.3 cm in size 
with masses increasing to about 0.4-0.6 cm after approxi- 
mately 500 hours of culture and over 0.6 cm after 800 hours 
of culture. 
The epithelial cells and mesenchymal cells used to seed 
the cultures were immunophenotyped and compared to the 
three-dimensional tissue cultured in the RWV. Samples were 
harvested at intervals during the culture process for immu- 
12 
nocytochemical analysis. The antibodies used to immu- 
nochemically characterize the cell types are listed in Table 
2 below. 
5 TABLE 2 
ANTIBODIES USED FOR IMMUNOCYTOCHEMICAL ANALYSIS 
Antibody SourceiOrder No. or 
Specificity Dilution Designation 
Pancytokeratin prediluted DAKO, Inc. iL1824 
Vimentin prediluted DAKO, Inc.lL1843 
Factor VI11 prediluted DAKO, Inc.iL1809 
Villin 1 2 0  Chemicon, Temacria, 
10 
CAiMAB 1671 
15 Sucrase 1 2 0  A. Elbein, UTHSCSAWI 
Angioblasts 1 2 0  Accurate Chem, West- 
Laminin 1 2 0  ICN, Costa Mesa, CAi69- 
Fibronectin 1 2 0  US BIOCH, Cleveland, 
20 Proteoglycan 1 2 0  Biological Products for 
bury, CAiHE3-5/47 
630 
OW33752 
Science, Oxford, UWMCA 
326 
Collagen Type IV 1 2 0  DAKO, Inc.iM785 
2s The keratin, vimentin, and Factor VI11 antibodies detect 
epithelial, fibroblastic, and endothelial cells, respectively. 
Villin is a cytoskeletal protein only found in epithelial cells 
from small intestine and colon. The angioblast marker is 
present in subsets of precursor endothelial cells, particularly 
30 dividing cells. Sucrase is an enzyme found in the epithelial 
cell brush border of the small intestine. Basement membrane 
and extracellular matrix components laminin, fibronectin, 
Collagen IV, and proteoglycan were also assayed to deter- 
mine their expression in the artificially produced three 
Cultured organ tissue grown on Cytodex-3 microcarriers 
in the RWV were fixed in OmniFix, an alcohol-based 
fixative not containing aldehydes or mercury (Xenetics 
Biochemic, Tustin, Calif.). At all times, extreme care was 
40 taken not to damage the delicate artificial tissue comprised 
of cellular material and microcarrier beads. When an abun- 
dance of beads was present, the supernatant fluid was 
carefully decanted and a sample of beads was enclosed in a 
biopsy bag, then placed in a cassette to prepare a paraffin 
45 block. When bead clusters were scarce, a Shandon Cytob- 
lock Kit (Shandon Inc., Pittsburgh, Pa.) was used. 
Cassettes were processed in a standard tissue processor. 
Five-micron sections were cut from the paraffin-embedded 
tissues, deparaffinized by standard procedures, then assayed 
SO by incubation with the test antibodies (Table 2) followed by 
use of the universal labeling streptavidin biotin (LSAB) kit 
(DAKO Inc., Carpenteria, Calif., No. K680), which detects 
mouse monoclonal and rabbit polyclonal antibodies. The 
immunocytophenotyping was confirmed by one positive and 
ss two negative controls. The positive control was normal 
tissue sections or normal cells positive for the primary 
antibody used. The negative controls were 1) PBS only, to 
test for false binding by “link” antibody and streptavidin, 
and 2) normal serum of the same species from which the 
Analysis by immunocytochemistry was used to confirm 
the ability of the seed cells to produce a three-dimensional 
artificially produced tissue mass with functional epithelial 
cells and functional mesenchymal cells as well as functional 
65 precursor endothelial cells that were not present in the seed 
culture. As the culture progressed and the tissue mass grew 
it included functional angioblasts. 
35 dimensional tissues. 
60 primary antibody was prepared. 
6,117,674 
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Immunophenotyping of the cell types used to seed the dehyde and 2% paraformaldehyde in 0.1 M cacodylate 
coculture in the RWV confirmed the majority of epithelial buffer at pH 7.4, then rinsed for 5 minutes with cacodylate 
and mesenchymal cells seeded were keratin and vimentin buffer three times and postfixed with 1% osmium tetroxide 
positive, respectively. In addition, the epithelial cells were at (Electron Microscopy Sciences, Fort Washington, Pa,) in 
various stages of differentiation. Only a small Percentage s cacodylate buffer for 1 hour. Samples were then rinsed for 
(<2%) of the cells was Positive for Factor VI112 an endot- 5 minutes with distilled water three times and then treated 
helial cell differentiation marker. Table 3 is a summary of the for 10 minutes with ~ i l l i ~ ~ ~ ~  ( ~ i l l i ~ ~ ~  carp,, ~ ~ d f ~ ~ d ,  
immunochemical staining reaction of the three dimensional Mass,) (o,2p) filtered, saturated solution of thiocarbohy- 
tissue of the present invention. The tissue was harvested at drazide (Electron Microscopy Sciences), then washed for 
i o  minutes with distilled water five times and fixed with 1% various intervals up to 41 days as noted in Table 3. An increased percentage 210% of cells present in the 
consisted of endothelial cells which were Factor vIII buffered osmium tetroxide for 10 minutes. This last step was 
positive as confirmed by immunochemistry and growing as necessary to prevent the microcarriers from collapsing. 
patches on the beads, Furthermore, a small percentage, Samples were then rinsed with distilled water three times 
1-2% of cells, showed de expression of the HE3 and dehydrated with increasing concentrations of EtOH 
angioblast antigen which was not present in the seed cultures After 
of mesenchymal cells confirming the presence of angioblasts transfer to 1~1~1~3~3~3-hexameth~1disi1azane (HMDS) 
borders were confirmed immunochemically by the presence soak for 10 minutes, drained, and air dried overnight. Dried 
samples were sprinkled with a thin layer of silver paint on of sucrase. 
FIG, is a photograph of the small intestine artificially 20 a specimen stub, dried, coated by vacuum evaporation with 
by three changes in 
in the tissue by immunochemistry, Functional cell brush Microscopy Sciences) were to 
produced organ tissue at ZOOx magnification showing the platinum-palladium and then examined in the JEoL 
three dimensional cell aggregate generally indicated by the T330 Scanning microscope at an 
arrows. FIG. 2 is a photograph of the small intestine organ 
tissue. The triangular markers at 2 and 4 in the photograph Micrographs taken Of '- to 7-day cocultures showed 
are for reference on the microcarriers, A of epithelial zs partial coverage of the microcarriers by normal small intes- 
ing on the microcarriers as shown at and FIG, is a masses of small intestine epithelium were evident, growing 
12 and 14, 30 rier packs which were totally engulfed in proliferating small 
displayed large tissue-like masses that were entirely covered 
with small intestine epithelium grown on a base layer of 
mesenchymal cells. Areas of organized columnar epithelium 
35 were prominent. As the cultures matured into mid- and 
late-stage cultures, extremely complex tissue-like masses 
comprised of mesenchymal and epithelial cells were seen 
from approximately 16 days of culture until termination at 
41 days. These tissues were assembled from smaller masses 
40 which were joined by cord-like structures of fibroblasts and 
Antibodies Cell Stained 13 23 2s 37 41 covered by epithelial cells several layers deep. In addition, 
available microcarriers were drawn to the surface of these 
large masses which were approximately 0.3 to 0.5 cm in Keratin Epithelial, Cyto- +++ +++ ++ ++ ++ 
Vimentin Fibroblasts, some +++ +++ ++ ++ ++ diameter. Finally, columnar epithelium was observed to be 
45 growing even in the recessed areas of the microcarrier bead 
The three-dimensional small intestine tissue mass was Villin Epithelial, small + + + + +  
HE3 Angioblasts - -  - ++ ++ grown under the above-described conditions for approxi- 
Sucrase Small intestine, +++ + ++ ++ ++ mately 45-50 days before the tissue mass was inoculated 
SO with Norwalk virus. The rotation of the RWV was stopped 
and the cells and tissue fragments in culture were allowed to 
Proteoglycan Extracellular ++++ ++++ ++++ ++++ ++++ settle by gravity onto the three-dimensional small intestine 
tissue mass. The volume of the culture media in the RWV 
Collagen Extracellular ++ + + ++ ND was aseptically reduced to approximately 10 ml using a 
ss vacuum suction apparatus. The tissue mass was inoculated 
with 50 pl of live Norwalk virus 8FIIa inoculum obtained 
*Slides were observed and scored on a relative scale as - from the Centers for Disease Control (Atlanta, Ga.). The 
(negative) to ++++ (maximum staining; very dark positive inoculum was added to the vessel and the culture and 
for >90% of the cells); inoculum gently mixed. The vessel was maintained with the 
+ indicates weaker staining for -25-50% of the cells; ++ 60 reduced volume of culture media for 1 h at 37" C. in an 
indicates moderate staining for greater than 50-75% of the atmosphere of 5% CO,. In alternate embodiments of the 
cells. invention, the media volume need not be reduced, or may be 
Samples from the RWV cultures were taken for scanning reduced by varying amounts. 
electron microscopy at the same times as those taken for After 1 h, the growth media volume was replenished to 
immunocytochemistry. After removal from the reactor 65 tissue culturing level. Thereafter, the growth media was 
vessels, samples were washed once with CMF-PBS. The changed at 24 h intervals for the first four days post 
samples were suspended in a buffer containing 3% glutaral- infection, and again at days 6 and 8 post infection. The 
age Of to lo kv. 
cells is shown at 6, Elongated mesenchymal cells are grow- tine large 
higher magnification (500~) of the epithelial mass shown at 
6 in FIG, 2, FIG, 4 shows the organized columnar epithelial 
FIG, 5 shows the three dimensional organ tissue masses intestine Micrographs Of at l3 days 
On the microcarrier beadpacks. 
approximately l2 days Of 
harvested at 
contained 
cells of the small intestine organ tissue at 
joined by cord-like structures of fibroblasts (mesenchymal 
cells) covered by epithelial cells. 
TABLE 3 
SUMMARY OF IMMUNOCHEMICAL STAINING ON TISSUE 
GROWTH IN RWV* 
Specificity or Davs Grown in RWV 
skeletal 
endothelial 
Factor VI11 Endothelial ++ +++ ++ ++ ++ packs, 
intestine 
cell brush border 
Laminin Basement membrane + + - + ++ 
Fibronectin Basement membrane + + ++ ++ - 
matrix 
Type IV matrix 
15 
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culture media was removed aseptically at each change by 
vacuum suction. The culture media was decanted off and 
saved for analysis. The tissue mass fragments remaining 
after decantation were also saved for analysis. Some cells 
were fixed in 2% buffered glutaraldehyde, and later embed- 
ded in epon blocks for electron microscopic study, and some 
cells were fixed in buffered 10% formalin, and embedded in 
paraffin blocks, using standard laboratory procedures. The 
pathogen culturing conditions were terminated at 8 days post 
infection. At day 8 post infection cell shedding was exten- 
time in both cell types. Following viral infection, the parallel 
cord arrangement of the uninfected fibroblasts degenerated 
in a progressive manner. These findings suggest a progres- 
sive pathologic process such as viral replication. 
Glucose utilization rate of the three-dimensional tissue 
mass in the RWV fell to 4 mgidlih at 6 and 8 days post 
infection, which correlates with the histological evidence of 
viral infection. Impaired or infected cells would be expected 
to have lower carbohydrate utilization. 
Electron microscopy performed with infected three- 
s 
i o  
sive. dimensional small intestinal tissue mass from 0, 6, and 8 
Virus replication in the cells of the three-dimensional days post infection revealed that mitochondrial swelling and 
tissue mass was determined using avidin-biotin immunoas- loss of cytoplasmic integrity had occurred starting at day 6 
say to determine the presence of viral antigen. The formalin post infection. Nuclear alterations were also noted on day 8 
fixed and paraffinized tissue culture cells were sectioned for is post infection. Cytoplasmic integrity had been lost in cells at 
histological evaluation. Additional sections were obtained day 8 post infection. The results confirmed the histological 
for immuperoxidase staining procedures with light micros- evidence of infection. 
copy. The glutaraldehyde fixed and epon-embedded tissue Immunohistological staining of Norwalk-infected forma- 
culture cells were sectioned for inspection by electron lin fixed and paraffinized tissue from the RWV was also 
microscopy. 20 performed. Acute and convalescent ( 2 2 3  weeks after 
Avidin-biotin immunoassay was performed according to illness) paired sera from four of Norwalk-challenged vol- 
standard procedures known to those skilled in the art to unteer donors were used for the immunohistological studies. 
detect Norwalk virus antigen. Gary et al., Detection of The sera were selected on the basis of their avidin-biotin 
Nonvalk Virus Antibodies and Antigen with a Biotin-Avidin solid-phase reactivity to Norwalk virus. Acute reciprocal 
Immunoassay, J .  Clin. Micvob., Vol 22, No.2:274-278 zs titers were 5 100 versus convalescent titers of 26400. The 
(August 1985); Johnson et al., Multiple-Challenge Study of acute and convalescent sera was used to stain the virus- 
Host Susceptibility to Nonvalk Gastroenteritis in US Adults, infected three-dimensional small intestine tissue. 
J .  Infect. Diseases, 161:18-21 (1990), incorporated by ref- Immunoperoxidase staining procedures known to those 
erence herein. Each test was performed in quadruplicate. skilled in the art, such as the avidin-biotin complex (ABC) 
The average of four wells utilizing a capture antibody of 30 immunoperoxidase staining procedure described by Burk et 
high titer of Nonvalk virus was compared to the average of al., Detection of non-A, non-B, hepatitis antigen by immu- 
four wells utilizing a capture antibody from a volunteer with nocytochemical staining, Pvoc. Natl .  Acad .  Sci., 
a low titer of Norwalk antibody obtained prior to experi- 81:3195-3199 (1984), incorporated by reference herein, 
mental infection. Absorbance was read at 470 nm. A may be used to ascertain the replication of Nonvalk virus in 
positiveinegative ratio (PIN) value of greater than 2 was 3s infected tissues or tissue culture cells. The paired donor sera 
considered positive, and indicative of the presence of Nor- were used as the primary antibody source on serial sections 
walk virus antigen. of tissue from the RWV. The sera was adsorbed first with 
The assays were performed twice on samples at undiluted rabbit liver powder in order to eliminate nonspecific back- 
concentrations and twice on samples from 0, 1 , 6  and 8 days ground reactivity. Biotinylated goat anti-human IgG was 
post infection which had been concentrated 10-fold by 40 used as the second antibody, followed by avidin-biotinylated 
gentle vacuum dialysis applied to a 10,000 MW exclusion horseradish peroxidase complex. The electron donor 3-3' 
dialysis membrane. A positive control was run on each diaminobenzidine-(HCI), was used in the presence of H,O,. 
microtiter plate. The acute sera reacted with uninfected tissues at a low 
After two blind testings, positive PIN values of 23.0 were background level. The intensity of the stain increased sev- 
reaeatedlv observed in unconcentrated samales collected at 4s eral fold when identical tissue sections were reacted with 
6 and 8 days post infection. The 10-fold concentrated 
samples from 1,6,  and 8 days post infection yielded average 
PIN values of 2.47, 3.72 and 5.35, respectively. Ten-fold 
concentration of day 0 supernatant (uninfected) yielded only 
a PIN of 0.01. The results show the generation of Norwalk 
viral antigens that are reactive in the avidin-biotin immu- 
noassay. A gradual increase of antigen production is sug- 
gested with ten-fold concentrates of supernates tested days 
2, 6 and 8 post-infection. 
Histological evaluation of the infected three-dimensional 
tissue mass was made based on hematoxylin and eosin- 
convalescent sera from the same volunteer. Immunostaining 
indicated that the nuclei of the cells were the predominant 
site of the antibody deposition. 
No paired sera reacted with uninfected tissues from the 
SO RWV. The acute sera from one volunteer exhibited a low 
level of reactivity with RWV tissue obtained at day 8 post 
infection. Serial sections from tissue were stained by the 
convalescent sera more intensely and with a greater number 
of cells. Another series of sections from Day 6 post infection 
ss stained with acute or convalescent sera from a second 
volunteer showed the intensity of the stain to be greater with 
stained sections of tissue harvested at 0, 1, 2, 3, 4, 6 and 8 convalescent serum. 
days post infection. The tissue was devoid of pathology Densitometer measurement of stained nuclei in photomi- 
through day 1 post infection. Epithelial and fibroblast nuclei crograph slides showed convalescent serum from two vol- 
were noted to be swollen beginning at day 2 post infection. 60 unteers was 1.53 and 3.47 times darker than that stained 
Hyperchromatic nuclei and mild degeneration of cytoplas- acute serum. These immunochemical results indicate that 
mic and nuclear components were noted by day 3 post Nonvalk virus can be propagated in the normal three- 
infection. Focal nuclear indentations and some inclusion dimensional small intestine tissue mass grown in the RWV. 
effect were found in cell nuclei at 4 and 6 days post Passage of 6 and 8 post infection virus into human 
infection. At 8 days post infection, prominent inclusions 65 embryonic lung fibroblasts resulted in baseline positive 
were found in both epithelial and fibroblast cells. Moderate levels of Norwalk virus antigen, as detected by avidin-biotin 
cytoplasmic and nuclear degeneration appeared at the same immunoassay, being observed after several weeks of culture. 
6,117,674 
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This provided further indication that Nonvalk virus was therapeutic agents, such as vaccines, drugs, and radiation, on 
successfully propagated in the RWV-grown tissue and RWV a pathogen infecting the host tissue can be tested prior to 
conditions. The three-dimensional tissue mass virus propa- administering the agent to a patient. Immunotherapeutic or 
gating system allows the replication a virus having chemotherapeutic treatments to alleviate or eradicate dis- 
biophysical, morphological, immunological, and biological s eases ranging from cancer and infections with high morbid- 
properties characteristic of Nonvalk virus isolated from ity and mortality through more benign maladies, such as 
human sources. rhinitis, may be developed. 
Normal three-dimensional tissue masses grown under the A virus propagated in the normal three-dimensional tissue 
microgravity conditions of the RWV provide a model for mass may also be premodulated to carry desired genetic 
successfully propagating pathogens in a normally active i o  information which will incorporate into the host cell DNA. 
tissue having normal functions. The three-dimensional tis- Gene therapy regimens may be defined by first culturing 
sue masses grown under microgravity conditions will pro- mammalian cells from a selected organ as described. Avirus 
vide a model for studying the propagation and mechanisms specific to the cells of the selected organ which has been 
by which pathogens function, and allow the development of encoded or manipulated to possess desired genetic material 
treatments for infectious and noninfectious pathogens. is may be transfected into the cells of the three-dimensional 
In particular, classical virus treatment dictates that large tissue mass. It can then be determined whether the desired 
quantities of a virus be grown for inactivation or attenuation genetic material is incorporated into the genome of the host 
and vaccination or multiple passages in order to develop a cells, thus replacing a particular genetic deficiency. 
viral vaccine. The three-dimensional tissue mass provides a Moreover, a virus possessing the ability to produce a desired 
high-fidelity tissue model necessary to maintaining viral 20 physiological effect my be transfected into the cells of the 
fidelity. Propagating viruses in three-dimensional tissue three-dimensional tissue mass. The three-dimensional tissue 
masses and associated extra-cellular matrices and interstitial mass will provide a model for determining whether desired 
components will provide insight into the mechanism by physiological effects will be obtained prior to attempting 
which a virus infects a cell, and the effects in relation to such therapy on animals and humans. 
promoters, growth factors, and cell type. The process by zs In an alternate process and embodiment of the present 
which a virus incorporates nucleotide sequences into the invention, three-dimensional tissue masses grown from 
host genome or utilizes the host biosynthetic capabilities to abnormal cells may be used to propagate pathogens. For 
replicate can also be studied. Critical pathways for viral example, aggregates of human urogenital tract carcinoma 
replication and the temporal sequence involved in replica- cells may be cultured in vitro to produce artificial high- 
tion may be observed as well. Other factors that may be 30 fidelity three-dimensional carcinomas. The artificially- 
studied utilizing the present invention include identifying produced carcinoma masses exhibit intact cell subpopula- 
the mechanisms and cell types involved in viral shedding, tions of differentiated and undifferentiated cells, stable 
and tracking the pathway by which the shed virus is trans- isoenzyme patterns, stable ploidy, stable and broad-based 
mitted to other hosts. cell growth patterns, high-fidelity expression of specific 
The three-dimensional tissue mass may be infected with 3s cellular proteins, specifically proteoglycan, and specific pro- 
a virus to achieve viral replication and thereby, antibody tein markers, such as Prostate Specific Antigen (PSA) and 
production, and an avenue to vaccine production. Large Prostatic Acid Phosphatase (PAP). 
quantities of virus with high-fidelity envelope and protein In an embodiment of the invention utilizing artificially- 
content will facilitate vaccine development and understand- produced high -fidelity three-dimensional  hum an 
ing of disease processes. Viral products, particularly 40 carcinomas, the carcinomas may be propagated from carci- 
proteins, are required in large amounts for vaccine devel- noma cells obtained from a carcinoma of selected origin. 
opment. The culture model described herein provides a Carcinoma cells may also be obtained directly from the 
means for propagating large quantities of previously difficult organ of carcinoma origin, or the organ of metastases. The 
to culture viruses. The culture model will assist in inferring carcinomas may be infected with a pathogen to obtain the 
the immunological mechanisms utilized to combat the infec- 4s results described herein for normal three-dimensional tissue 
tion. masses. It would be desirable to infect abnormal tissue 
Propagating and growing viruses in cultured three- masses with pathogens because of the rapid proliferation of 
dimensional tissue masses as provided may result in a virus cells generally observed with cancerous tissues. Abnormal 
that can be subsequently propagated in large quantities in three-dimensional tissue masses grown in a RWV may 
two-dimensional culture. Viruses are highly adaptive SO provide accelerated and increased production of pathogenic 
mechanisms because they attach to the genome of a host. compounds when infected. Abnormal tissue masses may 
The viruses grown in the artificially produced three- exhibit some confounding of proteins produced as compared 
dimensional tissue mass are adapted to the synthetic envi- to normal tissue, however, confounding factors can be 
ronment of the cultured tissue and the cells of the tissue. It checked against pathogen production in normal three- 
is likely that a virus which propagates in the three- ss dimensional tissue masses. 
dimensional tissue described herein will also propagate Methods for growing high-fidelity human urogenital tract 
under two-dimension culture conditions. Thus, it will be carcinomas in RWV culture are provided. Any carcinoma 
possible to passage a virus propagated in the three- cell line, however, may be grown according to the methods 
dimensional tissue mass to a two-dimensional culture. provided. Carcinoma cells may be cocultured with normal 
Adapting viruses which are difficult to culture in vitro to 60 human cells, such as normal fibroblasts established from 
successfully propagate and grow in two-dimensional culture primary cultures from the normal cells of organ donors. In 
will enable the production of the large quantities of virus and an alternate embodiment of the invention, the carcinoma 
viral product needed to develop vaccines and to perform cells may be cultured without the presence of normal 
research concerning such viruses. fibroblasts. It is preferred that the fibroblasts selected be 
dimensional tissue mass, the tissue, once infected, will allow Human prostate carcinoma cell lines designated PC3 and 
the testing of the efficacy of therapeutic agents. The effect of LnCap by convention and primarily undifferentiated pros- 
In addition to propagating pathogens in the three- 65 specific to the organ of interest. 
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tate carcinoma cell lines were obtained from American Type 
Culture Collection (ATCC, Rockville, Md.). The PC3 cells 
were ATCC no. CRL-1435 and the LnCap were ATCC no. 
CRL-1740. Both cell lines were successfully propagated 
according to the methods described herein. The normal cells 
selected were normal adult prostate fibroblasts established 
from primary cultures from the normal prostate of organ 
donors. The normal fibroblasts were obtained from Clonet- 
ics Corporation (San Diego, Calif.). 
The prostate carcinoma cells and normal prostate fibro- 
blasts were initiated and propagated separately in T-flasks 
containing a preferred culture media designated GTSF-2. A 
preferred formulation for GTSF-2 media is provided in 
Table 1 below. 
The carcinoma cells and the fibroblasts were grown in 
monolayer culture. GTSF-2 was found to meet the growth 
requirements of the monolayer cultures, and the subsequent 
culture vessel system, without the need for unique growth 
factors and other complex components found in other media. 
The GTSF-2 media is a tri-sugar-based medium containing 
the sugars: glucose, galactose and fructose supplemented 
with 7% fetal bovine serum (FBS). The pH of the media was 
adjusted to 7.4 with 1N NaOH. 
TABLE 1 
Component 
Tri-Sugar Based Medium 
GTSF-2 
SourceiOrder or 
Concentration Designation 
MEM-alpha supplemen- 
ted with 2.25 gmiL 
NaHCO, 
L-15 
NaHCO, 
HEPES 
Folic acid 
0.05% Nicotinic acid 
Bactopeptone 
I-Inositol 
Fructose 
Galactose 
D-Glucose 
300 mM L-Glutamine 
Gentamycin 
Fungizone 
Insulin-transferrin- 
sodium-solenite 
Fetal bovine serum 
400 ml (40%) GIBC0/430-1900EB 
600 ml (60%) 
1.35 gmiliter 
3.0 gmiliter 
6.667 ,@liter 
0.667 mliliter 
0.6 giliter 
0.024 giliter 
0.13 giliter 
0.25 giliter 
1.0 giliter 
10 mliliter 
1 mliliter 
2 mliliter 
5 mliliter 
GIBC0/430-1300EB 
Sigmais-5761 
Research Or- 
ganicsi6003H-2 
SigmaiF-8758 
SigmaiN-4126 
Difcoi0118-01 
SigmaiI-5125 
SigmaiF-3510 
SigmaiG-5388 
SiginaiG-5250 
SigmaiG-5763 
GIBC0/600-5750AD 
GIBC0/600-5295AE 
SigmaiI- 1884 
70 ml (7%) HycloneiA-1111-L 
The monolayer cell cultures were maintained in a humidi- 
fied CO, Forma incubator in 5% C0,:95% air constant 
atmosphere, and 98% humidity at a temperature of 37" C. 
When glucose in the cell culture media was depleted to 
20-60 mgidl, 50 to 100% of the culture media was replaced. 
Cell cultures were expanded when cells became confluent on 
the bottom of the T-flasks. Standard enzymatic dissociation 
with a solution of 0.1% Trypsin, 0.1% EDTA, in phosphate- 
buffered saline (PBS) solution for 15 minutes at 37" C., was 
used to separate the cells. 
Once the concentration of normal and carcinoma cells 
grown in monolayer culture was sufficient to provide the 
desired cell concentration for seeding into the culture vessel, 
the carcinoma cells and the normal fibroblasts were removed 
from the T-flasks. The cells were removed by enzymatic 
digestion with 0.1% Trypsin, 0.1% EDTA, for 15 minutes at 
37" C., and washed once with calcium- and magnesium-free 
PBS (CMF-PBS). The cells were assayed for viability using 
Trypan Blue stain exclusion (GIBCO). The cells were cen- 
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trifuged at 800xG for 10 minutes in conical 15-ml centrifuge 
tubes in GTSF-2 with 7% FBS. The cells were then resus- 
pended in fresh medium and diluted into Corning T-flasks 
with 25 ml of fresh growth medium. Cells were held on ice 
in fresh growth medium until inoculation into a culturing 
vessel (RWV). The carcinoma cells and the normal fibro- 
blasts cells were kept separate during preinoculation proce- 
dures. 
In the preferred method for culturing the cells, the primary 
inoculum of monodispersed normal cells introduced into the 
culture vessel was 4x10' normal prostate fibroblast cellsiml 
in the 110-ml volume vessel, with 5 mgiml (550 mg total) 
Cytodex-3 microcarrier beads (Pharmacia, Piscataway, 
N.J.). Cytodex-3 microcarriers were Type I, collagen-coated 
dextran beads, 175 microns in diameter. After the primary 
inoculum was prepared for seeding, it was transferred to a 
culture vessel filled with GTSF-2 with 7% FBS culture 
media and cultured at microgravity conditions. Rotation 
speed in the vessel was initially set at a rate of 12-14 rpm. 
In an alternate embodiment, a primary inoculum of the 
monodispersed prostate carcinoma cells was introduced into 
the culture vessel at 2x10' cellsiml in the 110 ml volume 
with 5 mgiml Cytodex-3 micro-carrier beads, as described 
above. 
In another embodiment, a primary inoculum of monodis- 
persed normal cells may be introduced into the culture 
vessel at 4x10' normal prostate fibroblast cellsiml with an 
inoculum of 2x10' prostate carcinoma cellsiml with 5 
mgiml Cytodex-3 microcarrier beads described above. 
Thereby, a coculture of prostate carcinoma cells and normal 
prostate fibroblasts will be present in the vessel at the 
initiation of culturing in the RWV. The RWV has been 
previously described herein. Rotation of the vessel was 
controlled as previously described herein. 
Culture conditions included mass transfer with exchange 
of nutrients for metabolic waste and appropriate gas 
exchange in the culture system. The culture medium was 
changed in response to glucose depletion. Fresh medium 
was replenished by 50% of the total vessel volume each 20 
to 24 hours. 
Within 48 hours of inoculation, the preferred primary 
inoculum of monodispersed normal human prostate fibro- 
blasts formed visible three-dimensional cellular aggregates. 
The fibroblast aggregates were maintained in solution 
through rotation of the RWV at 25 rpm. The fibroblasts were 
allowed to become confluent such that the beads were 
entirely covered before a coculture inoculum of 2x10' 
prostate carcinoma cellsiml was added to the culture vessel, 
resulting in a coculture of prostate carcinoma cells and 
normal cells. Although normal prostate fibroblasts were 
selected as the primary inoculum in the preferred 
embodiment, normal prostate mesenchymal cells, initiated 
and propagated as described herein for normal fibroblasts, 
may form the primary inoculum, inoculated at 4x10' normal 
mesenchyme cellsiml. 
The coculture process described allows carcinoma tissues 
to be engineered, or constructed, through the control of 
culture conditions and the introduction of cells. Tissue 
engineering of carcinoma growth enables the manipulation 
of the results of the culture system by introducing various 
carcinoma cell types into the culture system at different 
points during the culturing process to obtain the desired 
cellular growth and aggregate size. 
Alternately, the monodispersed carcinoma cells formed 
visible cellular aggregates at approximately 72 hours post 
inoculation. The prostate cell aggregates were maintained 
through rotation of the RWV at 25 rpm. The prostate cell 
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aggregates were maintained as a monoculture of prostate 
carcinoma cells. This culturing process also allows carci- 
noma tissues to be engineered, or constructed, through the 
control of culture conditions and the introduction of cells. 
In both embodiments, cells were allowed to grow until the 
aggregates exceeded 4 mm in diameter (approximately 11 to 
15 days) with minimal necrosis. When the aggregates 
reached the desired size, viable cell samples were harvested 
over periods of 3 to 4 days, and prepared for the following 
discussed analyses. Higher cell densities were observed with 
cocultured carcinoma cells than with the carcinoma cells 
cultured alone. Under the microgravity conditions, the car- 
cinoma and normal cells were observed to express morpho- 
logical and biochemical characteristics found in carcinoma 
cells in situ, and achieved three-dimensional cellular aggre- 
gates of up to 5 mm in diameter. 
The assessment of fidelity of the carcinoma cell aggre- 
gates was based upon the regulation of specific oncogene 
markers and protein markers. The assessment of fidelity 
relates to the in situ environment. Morphological and bio- 
chemical characteristics of the aggregates were observed 
using scanning electron microscopy and histology. Samples 
from RWV cultures were taken at multiple time points 
throughout the course of the culturing procedures for histo- 
logic analysis (approximately 72 hours post inoculation and 
then every 72 hours). Standard immunostaining procedures, 
including antibodies specific to vimentin, keratin, and 
cytokeratin, were also utilized to evaluate differentiation and 
the presence of cellular components. All procedures used to 
assess the fidelity of the carcinoma cell aggregates are 
known to those skilled in the art. 
Results of staining showed the cocultured and cultured 
prostate carcinoma cell aggregates to exhibit intact cell 
subpopulations of differentiated and undifferentiated cells. 
Cellular structures, such as microvilli, were observed. The 
cellular protein, proteoglycan, was specifically identified in 
the cells of the three-dimensional aggregates. Protein 
markers, Prostate Specific Antigen (PSA) and Prostatic Acid 
Phosphatase (PAP), were observed in the prostate carcinoma 
cell aggregates. 
Samples from the RWV cultures were taken for scanning 
electron microscopy at the same time as those taken for 
histological analysis. Micrographs taken of 3 to 5 day 
cultures showed substantial coverage of the microcarriers by 
three-dimensional prostate carcinoma cell aggregates. 
Microcarriers were uniformly covered with cell aggregates 
by 11 to 15 days of culturing in the vessel. 
A cDNA library created from cocultured prostate carci- 
noma cells cultured in T-flasks and a cDNA library created 
from cocultured prostate carcinoma cells cultured in a 
rotating wall vessel were used in a subtractive hybridization 
process to identify mRNA of specific expressions associated 
with the particular culture environment. Oncogenic markers 
known to be specific for the cell types studied were analyzed 
by the method of Pardee and Lang for isolation of mRNA. 
The subtractive hybridization process used to create the 
cDNA libraries is a standard, commercially available tech- 
nology (Invitrogen). AC-hasbas-1 probe was used to assess 
specific mRNA expression. 
By separation of mRNA and DNA, basic patterns of 
isoenzymes were observed and determined to be stable. 
Protein markers, PSA and PAP, which are specific markers 
for prostate tumors, were expressed. Stable ploidy was also 
demonstrated. The oncogene markers and protein markers 
form a basis for assessing fidelity and comparing transitions 
from models grown in T-flasks to the high-fidelity three- 
dimensional cultures grown as cocultures and monocultures 
in the RWV. 
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A cDNA library was also created for the monocultured 
cell aggregates cultured in T-flasks and a library created for 
monocultured cells cultured in the rotating wall vessel using 
the same technology described for the cocultured cell culture 
cDNA libraries. Similar results at the cellular and molecular 
level were observed. 
The assessment of carcinoma cell aggregate fidelity may 
also be based upon the ability of the aggregates to withstand 
successful transplantation into nude mouse models. The 
cocultured and monocultured prostate carcinoma cell aggre- 
gates will provide high-fidelity three-dimensional prostate 
carcinoma masses providing tumor models that closely 
resemble the carcinoma in situ. 
Artificially-produced human bladder carcinomas have 
also been propagated from carcinoma cells obtained from a 
human bladder carcinoma. The bladder carcinoma cell line 
propagated, designated T-24 by convention, is a primarily 
undifferentiated human bladder carcinoma cell line. The 
T-24 cell line is a mixed-bed carcinoma having a mixture of 
standard T-24 cell subpopulations. The bladder carcinoma 
cells were obtained from ATCC no. HTB 4. In the preferred 
embodiment of the inventive process, carcinoma cells were 
cocultured with normal human cells. The normal human 
cells were normal human bladder fibroblasts established 
from primary cultures from the normal bladders of organ 
donors. The normal human bladder fibroblast cell line was 
also obtained from Clonetics. 
The same procedures and techniques described herein 
with reference to the culturing of human prostate carcinoma 
cells were followed to prepare high-fidelity three- 
dimensional human bladder carcinoma cell aggregates 
resembling carcinomas found in situ. Bladder carcinoma 
cells were cocultured or monocultured as described. Fol- 
lowing culturing, the bladder carcinoma cell aggregates 
were analyzed as described above for prostate carcinomas. 
Similar characteristics of intact cell subpopulations of dif- 
ferentiated and undifferentiated cells, stable isoenzyme 
patterns, stable ploidy, stable and broad-based cell growth 
patterns and high-fidelity expression of specific cellular 
proteins, specifically proteoglycan, were observed with the 
bladder carcinoma cell aggregates as with the prostate 
carcinoma cells. The cocultured and monocultured human 
bladder carcinoma cell aggregates were found to be high- 
fidelity three-dimensional bladder carcinoma masses that 
provide tumor models that closely resemble the bladder 
carcinoma in situ. 
The high-fidelity three-dimensional carcinomas grown in 
the RWV may be inoculated with a virus or other pathogen 
for obtaining the advantages discussed above with normal 
three-dimensional tissue masses. Because abnormal, par- 
ticularly carcinoma or cancerous, cells are immortal and 
rapidly proliferating, there is a great number of cells con- 
tinually available to provide hosts for a virus. Abnormal 
mammalian cells grown into three-dimensional tissue 
masses will provide an environment for producing large 
quantities of a virus and viral products. 
Propagating pathogens in cultured high-fidelity three- 
dimensional carcinomas, as with normal three-dimensional 
tissue masses, will provide a means for assessing the thera- 
peutic value of a drug or other treatment. Utilizing the 
three-dimensional tissue masses for propagating pathogens 
will remove the psychological effects on a patient of taking 
or being exposed to a therapeutic agent, and the observer 
error when monitoring such treatments for likelihood of 
being successful as a therapy. All therapy assessments may 
be made under in vitro conditions which closely resemble in 
situ. Moreover, it could be used to formulate patient specific 
treatments and therapies. 
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In addition to viruses, other pathogens normally found 
undesirable in traditional tissue culture, such as bacteria and 
pleomorphic gram-negative non-motile mycoplasmas, are 
included in the Pathogens that may be cultured in three- 
dimensional tissue masses. Thus, the apparatus and method 5 
of the present invention are effective for replicating a broad 
spectrum of pathogens, including viruses, bacteria, and 
intermediate organisms such as mycoplasmas. 
The examples included are not intended to limit the scope 
of the present invention. Other substitutions, modifications i o  
and variations of the process for propagating pathogens are 
apparent to those skilled in the art without departing from 
the disclosure and scope of the invention. 
9. The process for propagating a pathogen of claim 1, 
wherein step (a) further comprises culturing normal mam- 
malian cells at microgravity conditions for a preselected 
time prior to adding carcinoma cells to the culture vessel. 
10, The process for propagating a pathogen of claim 1, 
wherein microgravity culture conditions are created by 
having a culture vessel in microgravity, 
11. The process for propagating a pathogen of claim 1, 
wherein microgravity culture conditions are created by 
simulating microgravity. 
12. The process for propagating a pathogen of claim 1, 
wherein microgravity culture conditions are created by 
having a horizontally rotating culture vessel in unit gravity What is claimed is: 
1, A process for propagating a pathogen comprising the producing the simultaneous conditions of (1) collocation of 
cells and culture matrix with similar or differing sedimen- 
a) culturing mammalian cells at microgravity conditions tation properties in a similar spatial region, (2) freedom for 
in a culture vessel containing culture media and a three dimensional spatial orientation of tissues formed by 
culture matrix capable of culturing the cells at micro- the culturing of the cells and (3) low shear and essentially no 
gravity culture conditions until the cells form a three- 20 relative motion of the culture environment with respect to 
dimensional tissue mass; the walls of the culture vessel. 
13. The process for propagating a pathogen of claim 1, 
wherein the culture media comprises fetal bovine serum and 
a tri-sugar based medium selected from mixtures of the 
steps o f  
b) inoculating the culture vessel with a pathogen; and 
c) maintaining the microgravity culture conditions 
whereby pathogen replication is achieved in the cells 
forming the three-dimensional tissue mass. 25 group consisting of fructose, galactose, and glucose. 
2, The process for propagating a pathogen of claim 1, 
wherein the mammalian cells are normal mammalian cells, 
14. The process for propagating a pathogen Of '3 
matrix comprises generally 'pherical wherein the 
3. The process for propagating a pathogen of claim 1, 
wherein the mammalian cells are normal mammalian cells 15. The process for propagating a pathogen of claim 1, 
selected from the group consisting essentially of epithelial 30 wherein the Pathogen is selected from the group consisting 
cells, mesenchyme cells, fibroblasts, and mixtures thereof. essentially of viruses, bacteria, Protozoans, Parasites, and 
4. The process for propagating a pathogen of claims 1, fungi. 
wherein the mammalian cells are abnormal mammalian 16. The process for propagating a pathogen of claim 1, 
cells. 
5. The process for propagating a pathogen of claim 1, 17. The process for propagating a pathogen of claim 1, 
wherein the mammalian cells are carcinoma cells. wherein step (b) further comprises reducing the culture 
6. The process for propagating a pathogen of claim 1, media volume prior to introducing the pathogen. 
wherein the mammalian cells are a mixture of small intestine 18. The process for propagating a pathogen of claim 1, 
epithelial cells and mesenchyme cells. 4o wherein the three-dimensional tissue mass is maintained 
7. The process for propagating a pathogen of claim 1, until tissue cell shedding occurs. 
wherein the normal mammalian cells are selected from the 19. The process for propagating a pathogen of claim 1, 
group consisting essentially of organ tissue cells, structural wherein the pathogen replicated in the culture vessel can be 
tissue cells, blood tissue cells, and mixtures thereof. passaged to a cell line under different culture conditions. 
20. The process for propagating a pathogen of claim 1, 
wherein step (a) further comprises culturing normal mesen- wherein the pathogen infects the three-dimensional tissue 
chyme cells at microgravity conditions for a preselected mass. 
time prior to adding normal epithelial cells to the culture 
vessel. * * * * *  
microcarriers. 
35 wherein the pathogen is Nonvalk virus. 
8. The process for propagating a pathogen of claim 1, 45 
